Publications
38 publications
Funding
6 grantsView NIH portfolio on RePORTER ↗
Active
3 grants- Co-IPREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint BiomarkersNational Cancer Institute · 2024–202975N91024D00006
- Co-IPREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Master AgreementNational Cancer Institute · 2024–202975N91024D00006
Completed grants (3)
- KPWeill Cornell Medicine (WCM) SPORE in Prostate CancerNational Cancer Institute · 2017–2023P50CA211024-05
- MPIAnti-Y. pestis Vaccination and Passive ProtectionNIAID · 2003–2007 · via NIH RePORTERR01AI055844-05
News mentions
1 mentionView all WCM news ↗
- Ritu Banga Healthcare Disparities Research Awards Support Innovative ScienceMay 22, 2025
Four Weill Cornell Medicine investigators received the Ritu Banga Healthcare Disparities Research Awards, recognizing innovative research that will help close care gaps in clinical settings.